XM does not provide services to residents of the United States of America.

Harris releases medical report, drawing contrast with Trump



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-Harris releases medical report, drawing contrast with Trump</title></head><body>

Updates with details from White House memo

By Jeff Mason

WASHINGTON, Oct 12 (Reuters) -Vice President Kamala Harris, the Democratic presidential nominee, released a letter from her doctor on Saturday that pronounced her in good health and fit for high office, in an effort to draw a contrast with her counterpart, Donald Trump.

In a memo distributed by the White House, the vice president's physician, Joshua Simmons, said Harris's most recent physical exam in April was "unremarkable," that she maintains an active lifestyle and "very healthy diet" despite a busy schedule, suffers from seasonal allergies and sporadic hives, does not use tobacco and drinks alcohol only in moderation.

"She possesses the physical and mental resiliency required to successfully execute the duties of the Presidency, to include those as Chief Executive, Head of State and Commander in Chief," the doctor wrote.

Harris, 59, is running againstRepublican Trump, 78, for the White House. She made her medical information public on Saturday in an effort to draw attention to his refusal to do so, according to a Harris aide.

The Harris campaign is eager to highlight the former president's age since he became the oldest candidate in the race after President Joe Biden, 81, stepped aside as the Democratic standard bearer following a poor debate performance against Trump.

Locked in a very tight race. Harris' campaign hopes that contrasting her comparative youth and mental acuity with Trump's more advanced age and tendency to meander, along with the differences in transparency between the two, will help convince undecided voters that she is more fit for office than he.

A White House doctor saidin 2018 when Trump was in office that he was in overall excellent health then but needed to shed weight and start a daily exercise routine.

Simmons said Harris's allergies had been well-managed with over-the-counter and prescription medications.

Her urticaria or hives were "sporadic and transient and do not seem to be triggered by any particular exposure nor are they associated with other symptoms" and respond well to antihistamine treatment.

Harris has been on allergen immunotherapy for the last three years, dramatically improving her allergy and urticaria symptoms and negating her need for medication other than occasional nasal spray, he said.

Harris wears contact lenses. Her family history includes her mother's colon cancer. Harris was up to date on preventative health procedures including colonoscopy and annual mammograms, he said.



Reporting by Jeff Mason; Editing by Sam Holmes and Diane Craft

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.